IDEXX Laboratories, Inc.
IDXX
$579.85
$2.730.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.82% | 17.94% | 44.61% | 3.01% | 11.12% |
| Total Depreciation and Amortization | 14.88% | 7.31% | 11.12% | 13.91% | 13.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 148.13% | 960.37% | 1,458.77% | 50.91% | 228.80% |
| Change in Net Operating Assets | 294.38% | 65.22% | -1,247.37% | 25.46% | -120.89% |
| Cash from Operations | 35.77% | 82.82% | -25.20% | 19.83% | 4.87% |
| Capital Expenditure | -0.61% | -10.77% | -2.39% | 0.82% | 10.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 112.32% | -3,414.94% | 19.10% | 26.44% | -599.20% |
| Cash from Investing | 29.40% | -63.95% | -2.19% | 72.31% | -30.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | 100.00% |
| Issuance of Common Stock | 34.81% | 920.22% | 223.20% | -65.55% | 16.99% |
| Repurchase of Common Stock | 3.33% | -8.74% | -57.27% | -146.75% | -566.44% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -52.80% | -7.67% | 21.22% | -129.27% | -128.57% |
| Foreign Exchange rate Adjustments | 99.75% | -111.05% | 1,500.00% | 42.77% | -309.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -37.93% | 146.87% | -84.99% | -120.00% | -116.66% |